![Jacobin | SteFou!](https://ifp.nyu.edu/wp-content/uploads/2024/03/1-114-1024x548.jpg)
Jacobin | SteFou!
Pharmacy benefit managers push expensive medications and slash drug reimbursement rates, pocketing the profits for themselves. Congress looked set to regulate these shadowy middlemen — but $50 million in industry lobbying later, the effort has stalled. Above: Small, independent pharmacies say that pharmacy benefit managers are putting them out of business.